- Home
- AIRS vs PROF Comparison
AIRS vs PROF Comparison
Compare AIRS & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIRS
- PROF
- Stock Information
- Founded
- AIRS 2012
- PROF N/A
- Country
- AIRS United States
- PROF Canada
- Employees
- AIRS N/A
- PROF N/A
- Industry
- AIRS Medical/Nursing Services
- PROF Medical/Dental Instruments
- Sector
- AIRS Health Care
- PROF Health Care
- Exchange
- AIRS Nasdaq
- PROF Nasdaq
- Market Cap
- AIRS 400.5M
- PROF 186.3M
- IPO Year
- AIRS 2021
- PROF N/A
- Fundamental
- Price
- AIRS $5.35
- PROF $7.24
- Analyst Decision
- AIRS Hold
- PROF Strong Buy
- Analyst Count
- AIRS 2
- PROF 2
- Target Price
- AIRS $5.00
- PROF $11.40
- AVG Volume (30 Days)
- AIRS 237.8K
- PROF 105.6K
- Earning Date
- AIRS 11-08-2024
- PROF 11-07-2024
- Dividend Yield
- AIRS N/A
- PROF N/A
- EPS Growth
- AIRS N/A
- PROF N/A
- EPS
- AIRS N/A
- PROF N/A
- Revenue
- AIRS $188,780,000.00
- PROF $8,984,000.00
- Revenue This Year
- AIRS N/A
- PROF $56.61
- Revenue Next Year
- AIRS $10.31
- PROF $160.87
- P/E Ratio
- AIRS N/A
- PROF N/A
- Revenue Growth
- AIRS N/A
- PROF 39.35
- 52 Week Low
- AIRS $2.92
- PROF $6.88
- 52 Week High
- AIRS $9.20
- PROF $11.42
- Technical
- Relative Strength Index (RSI)
- AIRS 38.88
- PROF 40.10
- Support Level
- AIRS $5.58
- PROF $7.00
- Resistance Level
- AIRS $6.60
- PROF $7.40
- Average True Range (ATR)
- AIRS 0.58
- PROF 0.40
- MACD
- AIRS -0.15
- PROF -0.07
- Stochastic Oscillator
- AIRS 0.43
- PROF 15.52
About AIRS AirSculpt Technologies Inc.
AirSculpt Technologies Inc is a national provider of body contouring procedures delivering a premium consumer experience under its brand Elite Body Sculpture. At Elite Body Sculpture, company provide custom body contouring using proprietary AirSculpt method that removes unwanted fat in a minimally invasive procedure.
About PROF Profound Medical Corp.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.